A smaller proportion of those with previous- and subsequent-year exacerbations were rated as having well-controlled asthma with AIRQ vs the other 3 assessment modalities. The Asthma Impairment and ...

Researchers identified 5 distinct clusters for disease exacerbation that went beyond disease labels for both asthma and chronic obstructive pulmonary disease (COPD). When examining common factors for ...

Please provide your email address to receive an email when new articles are posted on . Global Initiative for Asthma (GINA) guidelines recommend single maintenance and reliever therapy (SMART) for ...

How does the switch to a high-deductible health plan affect children with asthma? A new study suggests that enrollment in a high-deductible health plan (HDHP) may not be associated with changes in ...

PHOENIX, Arizona — In a 15-month phase 4 trial, an inexpensive intervention that can be explained in a single office visit reduced severe exacerbations and improved asthma control in patient ...

An asthma risk score using 7 clinically relevant parameters evaluated in a pediatric Medicaid managed care population can stratify risk for following-year asthma hospitalization. Objectives: ...

Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and ...

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...

Please provide your email address to receive an email when new articles are posted on . Single-inhaler fluticasone furoate/umeclidinium/vilanterol triple therapy ...

In an observational study reported at CHEST 2021, the American College of Chest Physicians annual meeting, Hanan Ajay, a fifth-year medical student at the University of Liverpool in England, said that ...

As many as 1 in 6 (16%) patients with asthma may have comorbid diabetes, with overweight and obesity playing a role. Researchers recently examined whether glucagon-like peptide-1 receptor agonists for ...